{
  "meta": {
    "data_length": 1,
    "message": "Document id doc:hse:00544 retrieved successfully",
    "request_url": "https://api.moalmanac.org/documents?document_id=doc%3Ahse%3A00544",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.001687,
    "timestamp_received": "2026-11-09T16:08:27.740564Z",
    "timestamp_returned": "2026-11-09T16:08:27.742251Z",
    "trace_id": "809b5c91-84ba-43b1-8ad8-ed2c57b816db"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://moalmanac.org",
    "last_updated": "2026-10-08"
  },
  "data": [
    {
      "id": "doc:hse:00544",
      "type": "Document",
      "documentType": "Regulatory approval",
      "name": "Atezolizumab Monotherapy. NCCP National SACT Regimen. HSE.",
      "title": null,
      "aliases": [],
      "description": "Atezolizumab Monotherapy, 2025, version number 14, NCCP National SACT Regimen, NCCP, viewed 26/03/2026, https://healthservice.hse.ie/documents/6644/544_v14_Atezolizumab_21_Day_Monotherapy.pdf",
      "urls": [
        "https://healthservice.hse.ie/documents/6644/544_v14_Atezolizumab_21_Day_Monotherapy.pdf"
      ],
      "doi": null,
      "pmid": null,
      "extensions": [
        {
          "name": "agent",
          "value": {
            "id": "agent:org:hse",
            "type": "Agent",
            "agentType": "organization",
            "name": "Health Service Executive",
            "description": "Regulatory agency that approves medicines for reimbursement by the public health system in the Republic of Ireland."
          },
          "description": "The organization that published this document."
        },
        {
          "name": "company",
          "value": "",
          "description": "The company that manufactures the cancer drug. Only applicable to market authorization documents."
        },
        {
          "name": "drug_name_brand",
          "value": null,
          "description": "The brand name of the cancer drug, per this document. Only applicable to market authorization documents."
        },
        {
          "name": "drug_name_generic",
          "value": null,
          "description": "The generic name of the cancer drug, per this document. Only applicable to market authorization documents."
        },
        {
          "name": "first_publication_date",
          "value": null,
          "description": "The publication date for the initial version of this document."
        },
        {
          "name": "publication_date",
          "value": "2024-06-14",
          "description": "The publication date for the document."
        },
        {
          "name": "regulatory_identifier",
          "value": null,
          "description": "Identifier assigned by the regulatory agency, such as an FDA application number (e.g. NDA208716, BLA125427) or an EMA product number (e.g. EMEA/H/C/006184)."
        },
        {
          "name": "status",
          "value": "Active",
          "description": "Whether this document is Active or Deprecated within moalmanac-db."
        }
      ]
    }
  ]
}